0001209191-14-059468.txt : 20140923 0001209191-14-059468.hdr.sgml : 20140923 20140923193247 ACCESSION NUMBER: 0001209191-14-059468 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100331 FILED AS OF DATE: 20140923 DATE AS OF CHANGE: 20140923 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KYTO BIOPHARMA INC CENTRAL INDEX KEY: 0001164888 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 651086538 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 41A AVENUE ROAD AT YORK SQUARE CITY: TORONTO ONTARIO STATE: A1 ZIP: 00000 BUSINESS PHONE: 416-955-0159 FORMER COMPANY: FORMER CONFORMED NAME: B TWELVE INC DATE OF NAME CHANGE: 20020111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MEDAREX INC CENTRAL INDEX KEY: 0000874255 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50390 FILM NUMBER: 141117006 BUSINESS ADDRESS: STREET 1: 707 STATE ROAD 206 CITY: PRINCETON STATE: NJ ZIP: 08540 BUSINESS PHONE: 9087136001 MAIL ADDRESS: STREET 1: 707 STATE ROAD 206 CITY: PRINCETON STATE: NJ ZIP: 08540 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50390 FILM NUMBER: 141117007 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER NAME: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 5 1 doc5.xml FORM 5 SUBMISSION X0306 5 2010-03-31 0 1 0 0001164888 KYTO BIOPHARMA INC KBPH 0000014272 BRISTOL MYERS SQUIBB CO 345 PARK AVENUE NEW YORK NY 10154 0 0 1 0 0000874255 MEDAREX INC C/O BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVENUE NEW YORK NY 10154 0 0 1 0 Common Stock 3 1300000 I By Medarex, L.L.C. Bristol-Myers Squibb Company ("BMS") recently identified its indirect ownership of 1,300,000 shares of common stock of Kyto Biopharma, Inc. ("Kyto"). These shares are owned directly by Medarex, L.L.C. (formerly known as Medarex, Inc.) ("Medarex"), a wholly-owned subsidiary of BMS. BMS acquired Medarex on September 1, 2009. At that time, Medarex owned 1,300,000 Kyto shares but only provided BMS with a stock certificate, in the name of Kyto's predecessor company B. Twelve, Inc., for 400,000 shares. Bristol-Myers Squibb Company, By: /s/ Katherine R. Kelly, Vice President & Assistant Secretary 2014-09-23 Medarex, L.L.C. (formerly known as Medarex, Inc.), By: /s/ Katherine R. Kelly, Secretary 2014-09-23